K. MOUNIKA et al. 2025. A RETROSPECTIVE ANALYSIS OF US FDA BREAKTHROUGH DEVICES PROGRAM: SETTING A GLOBAL REGULATORY BENCHMARK. The Bioscan. 20, Special Issue-3 (Oct. 2025), 1127–1136. DOI:https://doi.org/10.63001/tbs.2025.v20.i03.S.I(3).pp1127-1136.